MedWorld Advisors Presents: The DNA of a Successful M&A Process Webinar with MPO; Watch here!
MedWorld Advisors recently presented The DNA of Successful M&A Process, a webinar hosted by MPO. Weren’t able to attend? Click here to watch the recording so you too can learn how to strategically plan for M&A success, align objectives and long term goals, best practices, and more!
MedTech M&A 2025 – What’s happening?
It will be exciting to watch this M&A resurgence continue to take shape through 2025 and beyond.
Spine’s Evolving M&A Landscape
Whether through mergers and acquisitions or spinoffs, the spine sector looks significantly different than it did in 2020.
Tariff Tango: Why Asia Manufacturing Remains Relevant for the Medtech Industry
Asia has remained an industrial stalwart for its unique combination of cost efficiency, technological expertise, and scalability.
Orthopedic Innovation’s Past and Future
Ten years ago, finding orthopedic companies at CES was quite a surprise. Now, it’s more shocking to discover who’s missing.
Navigating through the tariffs in medical device manufacturing
Uncertainty in global trade policy is nothing new, but its impact on medtech manufacturing is becoming increasingly difficult to ignore.
The Value of an M&A Advisor Team Member—A Medtech Makers Q&A
When considering a sale of your company, be sure to work with an expert who has been through the process and knows how to prepare.
Is AI still the MedTech trend to look toward in 2025?
These are just a few of the AI trends we forecast for 2025. We’re energized and excited to see how improvements and innovations in AI will continue to improve healthcare.
2025 MedTech OEM Supplier and OEM Giant Industry Trends
As the backbone of MedTech manufacturing, OEM suppliers continued to grow in 2024.
MedWorld Advisors Completes Record Year in MedTech M&A in 2024, Heads to JPMorgan Healthcare Conference with New Deal Activity
2024 presented a positive M&A environment for profitable Healthcare companies with a growth story, a trajectory expected to continue into 2025.
M&A, Strategic Partnerships Shaped the Orthopedic Industry in 2024
The orthopedic and spine industries this year underwent rapid consolidation through strategic M&A and partnerships.
How the Fed’s Interest Rate Decrease Impacts MedTech, M&A, and Fundraising
In a somewhat unexpected move with positive implications for the MedTech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut.
Dave Sheppard Guests on Moore on Manufacturing Episode: Common Mistakes When Selling Your Business
Selling your business is usually the penultimate milestone in a business owner’s career. A lot depends on its success, including financial longevity, continued legacy and even personal pride. On this episode, hear Dave discuss common mistakes as well as best practices for avoiding those mistakes.
Watch Here! “The Impact of M&A In MedTech” Webinar hosted by MedWorld Advisors with Today’s Medical Developments
Hosted by our founders CEO Florence Joffroy-Black, and Managing Director Dave Sheppard, watch the webinar to find out how M&A changes the MedTech landscape and its impacts on those involved in manufacturing medical devices and equipment.
MedTech M&A leads the way into 2025!
From our perspective in working with private equity (PE) and strategic companies in 2024, mergers and acquisitions (M&A) continues to be highly active in medtech.
Will Orthopedic Robotics Contribute to Ambulatory Surgery Centers’ Success?
In our October column in ODT Magazine, we discuss how ASCs foster technological innovation that benefits both orthopedic implant developers and the centers themselves.
Will the U.S. Election Impact 2025 MedTech M&A Trends?
The election will stimulate more activity—depending, of course, on the political party that wins the presidency and control of the U.S. Congress.
MedWorld Advisors to feature on BizNexus Quarterly Webinar Update: State of Healthcare M&A
On October 17, 2024 at 2PM ET, join us for an insightful webinar presented by Managing Director Daniel Sheppard, where we’ll dive into the latest trends and forecasts in Healthcare M&A.
REGISTER TODAY for MedTech M&A Case Study: Cross-Border Deals, MDG webinar with MWA Managing Director, Daniel Sheppard
You won't want to miss Managing Director Daniel Sheppard discuss Cross-Border Deals in Healthcare M&A during this webinar being held October 11 2024 at 8AM PT.
Possible benefits of upcoming Fed rate cuts for medical industry manufacturers
The anticipated reductions in U.S. federal interest rates present opportunities for medical industry manufacturers and may also benefit those owners among us that are looking to sell.
Contact us.
We love what we do as we partner with our clients to bring them success. There are often many approaches to achieve your goals and will help you be successful. The best thing about our services is that YOU decide what YOU want to engage us for.
Connect with us for further details.
contact@medworldadvisors.com
(805) 441-0962
153 Summer Street
Andover, MA 01810